No Data
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Guofa Co., Ltd.: 2024 Annual Results Pre-loss Announcement
2024 Annual Results Advance Loss Announcement
Beihai Gofar Chuanshan Biological (600538.SH): Expected loss of around 89 million yuan for the year 2024.
Globe News on January 16 reported that Beihai Gofar Chuanshan Biological (600538.SH) announced a pre-loss notice for its 2024 annual performance. The company expects to achieve revenue of approximately 0.35 billion yuan in 2024, with a net income attributable to shareholders of the parent company expected to be around -89 million yuan. The net income attributable to shareholders of the parent company after deducting non-recurring gains and losses is also expected to be around -89 million yuan in 2024.
China Development Stock Report for the Third Quarter of 2024
Beihai Gofar Chuanshan Biological (600538.SH) announced the performance for the first three quarters, with a net loss of 20.88 million yuan.
Beihai Gofar Chuanshan Biological (600538.SH) disclosed the third quarter report for 2024, and the company achieved operating income in the first three quarters...
There's Reason For Concern Over Beihai Gofar Chuanshan Biological Co., Ltd.'s (SHSE:600538) Massive 26% Price Jump
